The thymus in immunodeficiency diseases: new therapeutic approaches

[T CD57+ lymphocytes in kidney transplanted patients. Phenotypic and functional study].

Presse medicale (Paris, France : 1983)·1992

[Routine application of HLA class II oligotyping. Value of automatization].

Presse medicale (Paris, France : 1983)·1992

Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

The Journal of clinical investigation·1992

Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome.

Transplantation·1992

Combined effects of a thymic peptide, thymopoietin and myasthenic patient sera in rat myotube culture.

Journal of the neurological sciences·1992

Acquired allo-tolerance to major or minor histocompatibility antigens indifferently contributes to preventing diabetes development in non-obese diabetic (NOD) mice.

Journal of autoimmunity·1992

Limb anomalies from evolutionary, developmental, and genetic perspectives.

Birth defects original article series·1996

Multisite neural tube closure in humans.

Birth defects original article series·1996

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

European journal of haematology·2026

Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case report.

Immunotherapy·2026

Macrophage metabolic reprogramming in organ transplantation: mechanisms, transplant outcomes, and therapeutic implications.

Frontiers in cellular and infection microbiology·2026

Low T3 Syndrome in Acute Myocardial Infarction: Association With Cardiac Biomarkers and Implications for Myocardial Injury Severity.

Cureus·2026

Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.

Frontiers in immunology·2026

Related Experiment Videos

The thymus in immunodeficiency diseases: new therapeutic approaches

Related Concept Videos

[T CD57+ lymphocytes in kidney transplanted patients. Phenotypic and functional study].

[Routine application of HLA class II oligotyping. Value of automatization].

Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome.

Combined effects of a thymic peptide, thymopoietin and myasthenic patient sera in rat myotube culture.

Acquired allo-tolerance to major or minor histocompatibility antigens indifferently contributes to preventing diabetes development in non-obese diabetic (NOD) mice.

Limb anomalies from evolutionary, developmental, and genetic perspectives.

Multisite neural tube closure in humans.

Intrasplenic Thymus Organogenesis from Injectable Tissue Fragments Restores Functional T-Cell Immunity.

Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

Low-dose interleukin-2 combined with thalidomide for a severe cutaneous immune-related adverse event associated with PD-1/CTLA-4 bispecific antibody therapy: a case report.

Macrophage metabolic reprogramming in organ transplantation: mechanisms, transplant outcomes, and therapeutic implications.

Low T3 Syndrome in Acute Myocardial Infarction: Association With Cardiac Biomarkers and Implications for Myocardial Injury Severity.

Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.

Related Experiment Videos

The thymus in immunodeficiency diseases: new therapeutic approaches

Related Concept Videos

Related Articles